ArticleInternational journal of clinical oncology2025

Phase-Ib dose-finding and pharmacokinetic trial of metformin combined with nivolumab for refractory/recurrent solid tumors.

Toshio Kubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.